KAMAZ Publicly Traded Balance Sheet Health
Financial Health criteria checks 2/6
KAMAZ Publicly Traded has a total shareholder equity of RUB57.6B and total debt of RUB108.5B, which brings its debt-to-equity ratio to 188.4%. Its total assets and total liabilities are RUB271.3B and RUB213.7B respectively. KAMAZ Publicly Traded's EBIT is RUB12.1B making its interest coverage ratio 2.1. It has cash and short-term investments of RUB23.1B.
Key information
188.4%
Debt to equity ratio
₽108.49b
Debt
| Interest coverage ratio | 2.1x |
| Cash | ₽23.10b |
| Equity | ₽57.59b |
| Total liabilities | ₽213.69b |
| Total assets | ₽271.28b |
Recent financial health updates
Recent updates
KAMAZ Publicly Traded (MCX:KMAZ) Shareholders Will Want The ROCE Trajectory To Continue
Dec 01
Is KAMAZ Publicly Traded (MCX:KMAZ) Using Too Much Debt?
Nov 10There's Been No Shortage Of Growth Recently For KAMAZ Publicly Traded's (MCX:KMAZ) Returns On Capital
Aug 29Returns At KAMAZ Publicly Traded (MCX:KMAZ) Are On The Way Up
May 24Statutory Profit Doesn't Reflect How Good KAMAZ Publicly Traded's (MCX:KMAZ) Earnings Are
Apr 26Should We Be Cautious About KAMAZ Publicly Traded Company's (MCX:KMAZ) ROE Of 3.3%?
Feb 14
Is There More Growth In Store For KAMAZ Publicly Traded's (MCX:KMAZ) Returns On Capital?
Jan 11The KAMAZ Publicly Traded (MCX:KMAZ) Share Price Has Gained 88% And Shareholders Are Hoping For More
Dec 06Financial Position Analysis
Short Term Liabilities: KMAZ's short term assets (RUB140.5B) exceed its short term liabilities (RUB121.3B).
Long Term Liabilities: KMAZ's short term assets (RUB140.5B) exceed its long term liabilities (RUB92.3B).
Debt to Equity History and Analysis
Debt Level: KMAZ's net debt to equity ratio (148.3%) is considered high.
Reducing Debt: KMAZ's debt to equity ratio has increased from 125.1% to 188.4% over the past 5 years.
Debt Coverage: KMAZ's debt is not well covered by operating cash flow (4.3%).
Interest Coverage: KMAZ's interest payments on its debt are not well covered by EBIT (2.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/05 12:52 |
| End of Day Share Price | 2022/07/08 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KAMAZ Publicly Traded Company is covered by 7 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Iouli E. Matevossov | Aton LLC |
| Natalia Sorokina | CiG |
| Anton Farlenkov | Goldman Sachs |